Travere Therapeutics' Change in Intangibles rose 83.69% to $15.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $48.6 million, marking a year-over-year increase of 51.40%. This contributed to the annual value of $36.2 million for FY2024, which is 12.93% down from last year.
Per Travere Therapeutics' latest filing, its Change in Intangibles stood at $15.0 million for Q3 2025, which was up 24.51% from $12.1 million recorded in Q2 2025.
In the past 5 years, Travere Therapeutics' Change in Intangibles registered a high of $27.3 million during Q1 2023, and its lowest value of $3.8 million during Q2 2023.
In the last 3 years, Travere Therapeutics' Change in Intangibles had a median value of $9.6 million in 2024 and averaged $10.6 million.
Per our database at Business Quant, Travere Therapeutics' Change in Intangibles soared by 432.26% in 2023 and then plummeted by 76.35% in 2024.
Quarterly analysis of 5 years shows Travere Therapeutics' Change in Intangibles stood at $5.0 million in 2021, then fell by 17.42% to $4.2 million in 2022, then spiked by 32.11% to $5.5 million in 2023, then surged by 75.17% to $9.6 million in 2024, then surged by 83.69% to $15.0 million in 2025.
Its last three reported values are $15.0 million in Q3 2025, $12.1 million for Q2 2025, and $11.8 million during Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value